This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 139 declarations
At Ascend Wellness Holdings, Inc., a US healthcare company listed on Nasdaq and valued at USD 79,684,888, option exercises (52) and sales (25) dominate a record of 103 filings from 12 filers. Sales total EUR 1,714,719, with a median of EUR 46,626; the 5 purchases total EUR 103,136, median EUR 24,634. Purchases are only 17% of open-market trades.
The largest sales are Daniel Joseph Neville's, a director and senior officer (EUR 298,771 on March 11, 2022), and Abner Brill Kurtin's, also a director and senior officer: EUR 223,458 on March 28, 2023 and EUR 210,462 on June 20, 2023. Abner Brill Kurtin is the top filer with 31 filings, 8 of them sales and none a purchase. John Richard Hartmann, a director, made the three largest purchases, in March 2024: EUR 34,135 on March 21, EUR 26,046 on March 22 and EUR 24,634 on March 21, 2024.
The yearly pace is 12 filings in 2022, 30 in 2023, 29 in 2024, 17 in 2025 and 15 in 2026. The 15 filings of the last twelve months include no purchase or sale. Insiders hold 20.3% of the shares, and filings appear a median of 3 days after the trade.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 500.6 m USD | -118.2 m USD | -0.58 USD | 10-K |
| Dec 2024 | 561.6 m USD | -85.0 m USD | -0.40 USD | 10-K |
| Dec 2023 | 518.6 m USD | -48.2 m USD | -0.24 USD | 10-K |
| Dec 2022 | 405.9 m USD | -80.9 m USD | -0.44 USD | 10-K |
| Dec 2021 | 332.4 m USD | -122.7 m USD | -0.82 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.